colorectal liver metastases
Conditions
Interventions
Navigated group:None
Non-navigated group:None
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.for a clinical diagnosis of CRLM between January 1, 2021 and January 31, 2023, patients were scheduled to undergo laparoscopic parenchymal-sparing hepatectomy; 2.at least 30% of the non-tumor remnant liver was free of underlying areas of ischemia or congestion; 3.there were no unresectable extrahepatic tumors; 4.underwent surgical treatment with a postoperative pathologically confirmed diagnosis of CRLM; 18-75 years of age; 5.Eastern Cooperative Oncology Group (ECOG) score of 0 or 1; 6.American Society of Anaesthesiologists (ASA) score of I, II, or III; 7.complete clinical data;
Exclusion criteria
Exclusion criteria: 1.previous history of liver resection; 2.history of concomitant radiofrequency ablation; 3.failure to perform a curative excision (R2 resection); 4.two-stage hepatic resection; 5.other diseases requiring concomitant surgery (except surgery for the primary lesion);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early postoperative complications rates; | — |
Secondary
| Measure | Time frame |
|---|---|
| intraoperative blood loss;Conversion rate;Intrahepatic recurrence rate within 1 year;R0 removal rate;Postoperative hospital stay;operation time; | — |
Countries
China
Contacts
Public ContactJian Yang
Zhujiang Hospital of Southern Medical University
Outcome results
None listed